Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Endomed AS
AS
Active
Org 813165082
Professor Birkelands Vei 34B, 1081
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1976 · 49 years old
3 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Endomed AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
TS
Trygve Steinar Gammelsæter
Chief Executive Officer
Chief Executive Officer
2006
Former (1)
VB
Vibeke Birkeli
Deputy Member
Deputy Member
2019 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
TS
Trygve Steinar Gammelsæter
Chairman
Chairman
2025
JC
Joachim Christian Meinich Frich
Board of Directors
Board of Directors
2023
Former (3)
SF
Sverre Frich
Chairman
Chairman
2023 – 2025
RA
Rolf Askvig Engelhardtsen
Board of Directors
Board of Directors
2023 – 2023
ES
Erik Storbekken
Board of Directors
Board of Directors
2023 – 2023
Shareholders
As of last annual report
Capitol Ii As — 95.62%
Trygve Steinar Gammelsæter — 4.38%
100%
Shareholder
Type
Ownership
Votes
Since
Capitol Ii As
Company
95.62%
95.62%
2025
Trygve Steinar Gammelsæter
Individual
4.38%
4.38%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Endomed AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network